We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

Bringing FISH Into the 21st Century

Technology Networks recently spoke with Brian Kirk, BioDot’s vice president of business development, to learn more about FISH, its advantages and applications. In this interview, Brian also highlights how new technology is tackling some of the limitations of classical FISH to bring the technique into the 21st century.
Industry Insight

Detecting a Change in Disease Trajectory With Synthetic Molecules

Technology Networks spoke with Dr. Caroline Loew, CEO of Glympse Bio to learn more about the use of activity-based biosensors in fibrotic disease.
Industry Insight

Next Generation Direct PCR for Molecular Diagnostics

In this interview, Dr. Huang discusses the advantages of the direct PCR approach and explains why uptake has so far not been greater.
Industry Insight

Anti-Müllerian Hormone (AMH) and Fertility Assessment

Clinicians have been using AMH in treatments related to reproductive health for over 20 years. High-quality diagnostic assays have come on in leaps and bounds over that time, continuing to provide precise insights to support clinical decisions made in the areas of reproductive aging, fertility and pregnancy monitoring.
Industry Insight

Connecting Biobanks With Biotech and Pharma Successfully

Technology Networks recently had the pleasure of speaking with Robert Hewitt, founder and manager of Biosample Hub, a unique platform designed to connect biotech and pharmaceutical companies with biobanks. Biosample Hub aims to help scientists obtain the samples they need to support the testing and development of novel therapeutics, diagnostics and vaccines, while establishing and maintaining biospecimen provenance information.
Industry Insight

NGS During the COVID-19 Pandemic and Beyond

Technology Networks recently spoke with Dr. Nick Downey, NGS collaborations lead at IDT, to learn more about the ways that NGS is being used as part of the response to the pandemic and gain insights into how and why this varies globally.
Industry Insight

A Novel Nasal Swab for Lung Cancer Detection

Technology Networks spoke to Dr. Giulia Kennedy, chief scientific officer and chief medical officer for Veracyte, to learn more about the Percepta Genomic Atlas and nasal swab tests for the diagnosis of lung cancer.
Industry Insight

Diagnostic Biomarkers in Human Primary Membranous Nephropathy: anti-PLA2R, anti-THSD7A and Beyond

In this article, we discuss the role of anti-PLA2R and anti-THSD7A antibodies in the diagnosis of primary membranous nephropathy and highlight why there is a need to measure these biomarkers before kidney transplants.

Industry Insight

The Antibody Test That Quantifies COVID-19 Vaccine Protection

Dr Stephen Russell explores how measuring neutralizing antibody levels can help understand how risk levels can change over time and determine optimal vaccine dosing strategies.
Industry Insight

Collaboration Between Organizations Is the Key to Getting Ahead of the COVID-19 Pandemic

Testing for the presence of the SARS-CoV-2 virus continues to be critical across the world, and will be in the future, particularly in light of new variants. The key to expanding and perfecting testing lies, arguably, in effective partnerships between organizations.
Advertisement